Rheumatoid Arthritis

Top Story

RA risk increased up to fivefold among patients with high CCP levels

RA risk increased up to fivefold among patients with high CCP levels
January 15, 2019
In the Journals

Single-infusion rituximab slows RA development in at-risk patients

January 10, 2019
A single 1,000-mg infusion of rituximab significantly slows the development of arthritis among patients at risk for rheumatoid arthritis, according to data published in…
In the Journals

Infection risk with abatacept lower than TNF inhibitors in RA

January 9, 2019
Patients with rheumatoid arthritis who are treated with abatacept as a first- or second-line biologic treatment have a lower risk for hospitalized infection compared…
In the Journals

Calprotectin levels predicts relapse in patients with RA, PsA treated with TNF inhibitors

January 9, 2019
Baseline calprotectin serum levels independently predict disease relapse in patients with rheumatoid arthritis and psoriatic arthritis who have achieved remission or low…
More Headlines »
CME

Rheumatic Complications of Cancer Immunotherapy: A New and Emerging Field in Rheumatology

This activity is supported by an educational grant from Bristol-Myers Squibb.

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new…
More »
Video
Meeting News

Baricitinib maintains safety profile in RA, shows promise for lupus

October 31, 2018
More »
CME ABIM MOC

Ace the Case: A 52-Year-Old Patient With Rheumatoid Arthritis Who Had an Inadequate Response to Methotrexate and a Tumor Necrosis Factor Inhibitor

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 52-year-old patient with rheumatoid…
More »